By David Tuller, DrPH So it’s time again to review my work and figure out what I’ve been doing. My crowdfunding from last April has been covering my half-time position at Berkeley since July 1, so December 31 marks the end of the first six months. The Berkeley fiscal year ends June 30th, so I …
By David Tuller, DrPH Carol Monaghan, a member of Parliament from the Glasgow area, has done it again. This week she is spearheading a three-hour debate in the House of Commons about the awful situation confronting ME patients in the UK. (The organizers of this debate are using ME, not CFS or ME/CFS or CFS/ME. …
Trial By Error: Carol Monaghan Scores Another Parliamentary Debate Read More »
By David Tuller, DrPH I was surprised recently when the UK press made a big splash about what was, in the end, a modest study from a team led by Carmine Pariante, a professor of psychiatry at Kings College London. I was less surprised when I realized that the Science Media Centre was involved in …
Trial By Error: More Thoughts on the Interferon Study Read More »
By David Tuller, DrPH Alan Montgomery is a professor of medical statistics and clinical trials at the University of Nottingham€™s School of Medicine. He is also the senior author of the Lightning Process study published in 2017 in Archives of Disease in Childhood, a BMJ journal. Professor Montgomery formerly worked at University of Bristol, along …
Trial By Error: My Letter to LP Study’s Senior Author Read More »
By David Tuller, DrPH In addition to giving a couple of talks in Norway, I also answered some questions from Trude Schei, assistant Secretary General of the Norwegian ME Association. I doubt I said anything I haven’t stated many times before. However, members of the GET/CBT ideological brigades–in Norway and elsewhere–continue to maintain against all …
By David Tuller, DrPH Earlier this month, NIH director Francis Collins and other agency officials held a meeting with five representatives from #MEAction. According to the group’s post about the meeting, the goal was to discuss accelerating research in order to more rapidly provide diagnostics and treatments to people with ME. Specifically, #MEAction urged the …
Trial By Error: “Talk is Cheap,” Patients Tell NIH Read More »
